Cabenuva (cabotegravir/rilpivirine) has potential interactions with other medications and some supplements. These interactions could affect how well the drug works or ...
When ViiV Healthcare and Johnson & Johnson launched their once-monthly injectable HIV treatment Cabenuva in 2021, they predicted that patients would prefer that option to the need to take tablets ...
Hosted on MSN12mon
First Long-Acting Injectable HIV Treatment Works Better Than Daily Pills For Some Patients, GSK SaysCabenuva contains two different antiviral drugs, cabotegravir and rilpivirine, in an extended-release formulation. Like other HIV medications, the drugs do not cure HIV infection but do help stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results